A nurse is caring for a client with a new tracheostomy. Which of the following actions should the nurse prioritize to prevent complications?

Choice A reason: Methylprednisolone, a corticosteroid, reduces inflammation in anaphylaxis by inhibiting immune responses. However, its onset is slow, taking hours to act, making it unsuitable as the first-line treatment for acute anaphylactic shock. It is used as an adjunct to stabilize symptoms after epinephrine addresses immediate life-threatening bronchoconstriction and hypotension.

Choice B reason: Epinephrine is the first-line treatment for anaphylactic shock. It acts rapidly via alpha- and beta-adrenergic receptors to reverse bronchoconstriction, vasodilation, and hypotension. It constricts blood vessels, increases cardiac output, and relaxes airway smooth muscles, alleviating life-threatening symptoms like airway obstruction and shock, making it critical for immediate administration.

Choice C reason: Dobutamine, a beta-agonist, enhances cardiac contractility and is used in cardiogenic shock. It does not address the histamine-mediated vasodilation, bronchoconstriction, or angioedema in anaphylaxis. Its use could worsen hypotension by increasing cardiac demand without correcting the underlying immune-mediated mechanisms, making it inappropriate for this emergency.

Choice D reason: Furosemide, a diuretic, treats fluid overload in conditions like heart failure. In anaphylactic shock, it would exacerbate hypotension by reducing intravascular volume, worsening tissue perfusion. Anaphylaxis involves histamine-induced vascular leak, not fluid overload, so furosemide is contraindicated and would not address the acute airway or cardiovascular symptoms.

Choice A reason: Omeprazole, a proton pump inhibitor, reduces gastric acid production by irreversibly inhibiting the H+/K+-ATPase enzyme in parietal cells. This decreases acid-related damage to the gastric mucosa, promoting healing of peptic ulcers. It is highly effective for H. pylori-associated ulcers when combined with antibiotics, making it a standard choice for peptic ulcer treatment.

Choice B reason: Ranitidine, an H2 receptor antagonist, reduces acid secretion by blocking histamine receptors on parietal cells. While effective for mild ulcers, it is less potent than proton pump inhibitors like omeprazole for severe cases or H. pylori-related ulcers. It is not the first-line choice for peptic ulcer disease in most modern treatment protocols.

Choice C reason: Sucralfate forms a protective barrier over the ulcer, shielding it from acid and pepsin, promoting healing. It does not reduce acid production, unlike proton pump inhibitors. While useful as an adjunct, it is not a proton pump inhibitor, so it would not be the anticipated medication in this context.

Choice D reason: Metronidazole is an antibiotic used in H. pylori eradication regimens, often combined with proton pump inhibitors and other antibiotics. It does not reduce gastric acid or directly treat ulcers. Its role is to eliminate bacterial infection, not to inhibit acid production, so it is not classified as a proton pump inhibitor.